MAPT and Alzheimer disease: Key markers include Aβ peptides, phosphorylated tau (p‐tau) species, neurofilament light chain (NfL) protein, and glial fibrillary acidic protein (GFAP), all of which are involved in the pathophysiological processes of AD and neurodegeneration.2, 7